ORAMED PHARMACEUTICALS INC. Available-for-sale Securities, Amortized Cost Basis
ORAMED PHARMACEUTICALS INC. (ORMP) had Available-for-sale Securities, Amortized Cost Basis of $9.26 million as of 2021-02-28, per its 10-Q filed 2021-04-13.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesAmortizedCost · last filed 2021-04-13
- 2021-02-28: Available-for-sale Securities, Amortized Cost Basis $9.26M.
- 2020-11-30: Available-for-sale Securities, Amortized Cost Basis $8.05M.
- 2020-08-31: Available-for-sale Securities, Amortized Cost Basis $9.30M.
- 2020-05-31: Available-for-sale Securities, Amortized Cost Basis $9.22M.
| Period end | Available-for-sale Securities, Amortized Cost Basis |
|---|---|
| 2021-02-28 | $9.26M 10-Q · filed 2021-04-13 |
| 2020-11-30 | $8.05M 10-Q · filed 2021-01-14 |
| 2020-08-31 | $9.30M 10-Q · filed 2021-04-13 |
| 2020-05-31 | $9.22M 10-Q · filed 2020-07-07 |
| 2020-02-29 | $2.01M 10-Q · filed 2020-04-06 |
| 2019-11-30 | $2.90M 10-Q · filed 2020-01-09 |
| 2019-08-31 | $4.13M 10-K · filed 2020-11-24 |
| 2019-05-31 | $4.59M 10-Q · filed 2019-07-10 |
| 2019-02-28 | $5.25M 10-Q · filed 2019-04-10 |
| 2018-11-30 | $6.08M 10-Q · filed 2019-01-14 |
| 2018-08-31 | $6.08M 10-K · filed 2019-11-27 |
| 2018-05-31 | $5.21M 10-Q · filed 2018-07-12 |
| 2018-02-28 | $5.63M 10-Q · filed 2018-04-09 |
| 2017-11-30 | $6.00M 10-Q · filed 2018-01-11 |
| 2017-08-31 | $4.01M 10-K · filed 2018-11-28 |
| 2017-05-31 | $3.39M 10-Q · filed 2017-07-06 |
| 2017-02-28 | $3.82M 10-Q · filed 2017-04-05 |
| 2016-11-30 | $3.40M 10-Q · filed 2017-01-11 |
| 2016-08-31 | $2.68M 10-K · filed 2017-11-29 |
| 2015-08-31 | $1.88M 10-K · filed 2016-11-25 |
| 2013-11-30 | $18.45K 10-Q · filed 2014-01-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |